证券记录 · 已归档季度
PGNY
Progyny, Inc. · Healthcare · Medical - Healthcare Plans
18被追踪持有人
+2Δ持有人
41.38M持有股份
$910.37M报告持仓市值
+2新建仓位
−0清仓
动量输入(同类管理人):
持有人广度 +12.5% ·
股份流向 -1.6% ·
净新建仓位 +11.1%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 71.83K | $1.90M | n/a | n/a |
| Q2 2026 | 111 | +7 | 55.02M | $1.59B | +10 | −2 |
| Q1 2026 | 106 | -1 | 57.93M | $989.34M | +8 | −10 |
| Q4 2025 | 108 | +1 | 64.14M | $1.65B | +4 | −2 |
| Q3 2025 | 20 | 0 | 47.53M | $1.02B | +1 | −2 |
| Q2 2025 | 18 | +2 | 41.38M | $910.37M | +2 | n/a |
| Q1 2025 | 13 | +1 | 12.87M | $287.47M | +2 | −1 |
| Q4 2024 | 12 | +3 | 10.40M | $179.35M | +3 | n/a |
| Q3 2024 | 8 | -3 | 5.55M | $93.05M | +1 | −4 |
| Q2 2024 | 11 | n/a | 4.74M | $135.69M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 14.58M | n/a | $320.79M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 9.87M | n/a | $217.15M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 4.71M | n/a | $103.68M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (被动) | 2.87M | -1.6% | $63.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.74M | -3.3% | $38.38M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 1.68M | +7.7% | $37.02M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 1.38M | -6.9% | $30.33M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 8 | Baillie Gifford ✦ | 1.27M | -0.7% | $27.88M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 9 | Renaissance Technologies ✦ | 727.80K | 新增 | $16.01M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 687.46K | +4.0% | $15.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 11 | Point72 Asset Management ✦ | 444.74K | 新增 | $9.78M | 0.0% | New | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 426.75K | -67.2% | $9.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 327.39K | -69.3% | $7.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 303.35K | -8.7% | $6.67M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 15 | Two Sigma Investments ✦ | 169.69K | -47.4% | $3.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Norges Bank ✦ (被动) | 77.13K | 0.0% | $1.70M | 0.0% | Held | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 59.05K | +7.0% | $1.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 51.86K | +338.1% | $1.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $16.01M | 0.0% |
| Point72 Asset Management | $9.78M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 283 持有人, 69.63M 股份, $1.17B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 14
Cummings Melissa B
Officer · 1.88K 股 · $52,612
Sep 23
Swartz Allison
Officer · 3.90K 股 · $101,868
Sep 10
GORDON KEVIN K
Director · 11.50K 股 · $321,358
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
Jun 08
SC 13G/A: KLEINER PERKINS CAUFIELD & BYERS XIII…
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据